These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 18023097

  • 1. Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome.
    Wang SH, Dong L, Luo JY, Gong J, Li L, Lu XL, Han SP.
    World J Gastroenterol; 2007 Dec 07; 13(45):6041-7. PubMed ID: 18023097
    [Abstract] [Full Text] [Related]

  • 2. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
    Cremon C, Carini G, Wang B, Vasina V, Cogliandro RF, De Giorgio R, Stanghellini V, Grundy D, Tonini M, De Ponti F, Corinaldesi R, Barbara G.
    Am J Gastroenterol; 2011 Jul 07; 106(7):1290-8. PubMed ID: 21427712
    [Abstract] [Full Text] [Related]

  • 3. Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection--an observation in a small case control study.
    Kim HS, Lim JH, Park H, Lee SI.
    Yonsei Med J; 2010 Jan 07; 51(1):45-51. PubMed ID: 20046513
    [Abstract] [Full Text] [Related]

  • 4. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C, Lobo B, Pigrau M, Ramos L, González-Castro AM, Alonso C, Guilarte M, Guilá M, de Torres I, Azpiroz F, Santos J, Vicario M.
    Gut; 2013 Aug 07; 62(8):1160-8. PubMed ID: 22637702
    [Abstract] [Full Text] [Related]

  • 5. Mast cells are increased in the small intestinal mucosa of patients with irritable bowel syndrome: A systematic review and meta-analysis.
    Robles A, Perez Ingles D, Myneedu K, Deoker A, Sarosiek I, Zuckerman MJ, Schmulson MJ, Bashashati M.
    Neurogastroenterol Motil; 2019 Dec 07; 31(12):e13718. PubMed ID: 31498961
    [Abstract] [Full Text] [Related]

  • 6. Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation.
    Foley S, Garsed K, Singh G, Duroudier NP, Swan C, Hall IP, Zaitoun A, Bennett A, Marsden C, Holmes G, Walls A, Spiller RC.
    Gastroenterology; 2011 May 07; 140(5):1434-43.e1. PubMed ID: 21315720
    [Abstract] [Full Text] [Related]

  • 7. Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome.
    Yang J, Wang P, Liu T, Lin L, Li L, Kou G, Zhou R, Li P, Li Y.
    BMC Microbiol; 2021 Nov 13; 21(1):316. PubMed ID: 34773967
    [Abstract] [Full Text] [Related]

  • 8. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.
    Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW.
    J Gastroenterol Hepatol; 2008 Nov 13; 23(11):1689-94. PubMed ID: 19120860
    [Abstract] [Full Text] [Related]

  • 9. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.
    Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM, Moses PL.
    Gastroenterology; 2004 Jun 13; 126(7):1657-64. PubMed ID: 15188158
    [Abstract] [Full Text] [Related]

  • 10. A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.
    Doyle LA, Sepehr GJ, Hamilton MJ, Akin C, Castells MC, Hornick JL.
    Am J Surg Pathol; 2014 Jun 13; 38(6):832-43. PubMed ID: 24618605
    [Abstract] [Full Text] [Related]

  • 11. Quantification of mucosal EEC in jejunum. A comparative study of IBS patients and healthy controls.
    Mohammadian G, Dlugosz A, Shetye J, Lindberg G.
    Scand J Gastroenterol; 2020 May 13; 55(5):543-548. PubMed ID: 32442056
    [Abstract] [Full Text] [Related]

  • 12. Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome.
    Liu DR, Xu XJ, Yao SK.
    World J Gastroenterol; 2018 Jan 07; 24(1):46-57. PubMed ID: 29358881
    [Abstract] [Full Text] [Related]

  • 13. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.
    Guilarte M, Santos J, de Torres I, Alonso C, Vicario M, Ramos L, Martínez C, Casellas F, Saperas E, Malagelada JR.
    Gut; 2007 Feb 07; 56(2):203-9. PubMed ID: 17005763
    [Abstract] [Full Text] [Related]

  • 14. Mucosal Serotonin Reuptake Transporter Expression in Irritable Bowel Syndrome Is Modulated by Gut Microbiota Via Mast Cell-Prostaglandin E2.
    Gao J, Xiong T, Grabauskas G, Owyang C.
    Gastroenterology; 2022 Jun 07; 162(7):1962-1974.e6. PubMed ID: 35167867
    [Abstract] [Full Text] [Related]

  • 15. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, Kim JJ, Rhee JC.
    J Gastroenterol Hepatol; 2006 Jan 07; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [Abstract] [Full Text] [Related]

  • 16. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.
    Martínez C, Vicario M, Ramos L, Lobo B, Mosquera JL, Alonso C, Sánchez A, Guilarte M, Antolín M, de Torres I, González-Castro AM, Pigrau M, Saperas E, Azpiroz F, Santos J.
    Am J Gastroenterol; 2012 May 07; 107(5):736-46. PubMed ID: 22415197
    [Abstract] [Full Text] [Related]

  • 17. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients.
    Kerckhoffs AP, Ter Linde JJ, Akkermans LM, Samsom M.
    Neurogastroenterol Motil; 2008 Aug 07; 20(8):900-7. PubMed ID: 18363639
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome.
    Dunlop SP, Coleman NS, Blackshaw E, Perkins AC, Singh G, Marsden CA, Spiller RC.
    Clin Gastroenterol Hepatol; 2005 Apr 07; 3(4):349-57. PubMed ID: 15822040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.